The Siblings With Ischemic Stroke Study (SWISS): A progress report

Clinical Medicine and Research

Volumn 4, Issue 1, 2006, Pages 12-21

  Meschia, James F ^a   Kissela, Brett M ^c   Brott, Thomas G ^a   Brown Jr , Robert D ^b   Worrall, Bradford B ^d   Beck, Jeanne ^e   Skarp, Alexa N ^a  

^a MAYO CLINIC   (United States)

^b Department of Neurology ^*  (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e Laboratory of Molecular and Cellular Biology of Hematopoiesis   (United States)

Author keywords

Cerebral infarction; Ischemic stroke; Pedigree research; Proband; Recruitment; SWISS

Indexed keywords

CEREBROVASCULAR ACCIDENT; HUMAN; MEDICAL RESEARCH; PEDIGREE ANALYSIS; PHENOTYPE; QUESTIONNAIRE; REVIEW; SIBLING;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ADULT; AGED; AGED, 80 AND OVER; CEREBROVASCULAR ACCIDENT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; QUESTIONNAIRES; REGISTRIES; RESEARCH DESIGN; SAMPLE SIZE; SIBLINGS;

EID: 33646078795     PISSN: 15394182     EISSN: None     Source Type: Journal    
DOI: 10.3121/cmr.4.1.12     Document Type: Review

References (32)

1. American Stroke Association, Heart Disease and Stroke Statistics - 2005 Update. American Heart Association Web site. Available at: http://www. americanheart.org/downloadable/heart/110539091811 9HDSStats2005Update.pdf. Accessed November 17, 2005.
2. Flossmann E, Schulz UG, Rothwell PM. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 2004;35:212-227.
3. Casas JP, Hingorani AD, Bautista LE, Sharma P. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch Neurol 2004;61:1652-1661.
4. Meschia JF, Brown RD Jr, Brott TG, Chukwudelunzu FE, Hardy J, Rich SS. The Siblings With Ischemic Stroke Study (SWISS) protocol. BMC Med Genet 2002;3:1.
5. WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 1988;41:105-114.
6. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
7. Madden KP, Karanjia PN, Adams HP Jr, Clarke WR. Accuracy of initial stroke subtype diagnosis in the TOAST study. Trial of ORG 10172 in Acute Stroke Treatment. Neurology 1995;45:1975-1979.
8. Meschia JF, Brott TG, Chukwudelunzu FE, Hardy J, Brown RD Jr, Meissner I, Hall LJ, Atkinson EJ, O'Brien PC. Verifying the stroke-free phenotype by structured telephone interview. Stroke 2000;31:1076-1080.
9. Jones WJ, Williams LS, Meschia JF. Validating the Questionnaire for Verifying Stroke-Free Status (QVSFS) by neurological history and examination. Stroke 2001;32:2232-2236.
10. Meschia JF, Lojacono MA, Miller MJ, Brott TG, Atkinson EJ, O'Brien PC. Reliability of the questionnaire for verifying stroke-free status. Cerebrovasc Dis 2004;17:218-223.
11. Castillo PR, Brott TG, Alvarez S, Meschia JF. Creation of a bilingual Spanish-English version of the Questionnaire for Verifying Stroke-free Status. Neuroepidemiology 2004;23:236-239.
12. Worrall BB, Chen DT, Brown RD Jr, Brott TG, Meschia JF; SWISS. A survey of the SWISS researchers on the impact of sibling privacy protections on pedigree recruitment. Neuroepidemiology 2005;25:32-41.
13. Hartmann A, Rundek T, Mast H, Paik MC, Boden-Albala B, Mohr JP, Sacco RL. Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology 2001;57:2000-2005.
14. Meschia JF, Brown RD Jr, Brott TG, Hardy J, Atkinson EJ, O'Brien PC. Feasibility of an affected sibling pair study in ischmic stroke: results of a 2-center family history registry. Stroke 2001;32:2939-2941.
15. Meschia JF, Brott TG, Hardy J, Brown RD, Dodick DW, Cornwell KB. Genome-wide screen for stroke: pilot testing in the Siblings With Ischemic Stroke Study (SWISS). J Stroke Cerebrovasc Dis 2000;9:276-281.
16. Worrall BB, Chen DT, Meschia JF. Ethical and methodological issues in pedigree stroke research. Stroke 2001;32:1242-1249.
17. Wadman M. US geneticists encouraged to play by the book. Nature 2000;404:530.
18. Chen DT, Worrall BB, Brown RD Jr, Brott TG, Kissela BM, Olson TS, Rich SS, Meschia JF; SWISS Investigators. The impact of privacy protections on recruitment in a multicenter stroke genetics study. Neurology 2005;64:721-724.
19. Beck JC, Beiswanger CM, John EM, Satariano E, West D. Successful transformation of cryopreserved lymphocytes: a resource for epidemiological studies. Cancer Epidemiol Biomarkers Prev 2001;10:551-554.
20. Doyle A, Griffiths JB. Mammalian cell culture: essential techniques. Chichester, England: John Wiley & Sons; 1997.
21. Armstrong K, Micco E, Carney A, Stopfer J, Putt M. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 2005;293:1729-1736.
22. Pope JH, Home MK, Scott W. Transformation of foetal human leukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus. Int J Cancer 1968;3:857-866.
23. Sugimoto M, Furuichi Y, Ide T, Goto M. Incorrect use of "immortalization" for B-lymphoblastoid cell lines transformed by Epstein-Barr virus. J Virol 1999;73:9690-9691.
24. Sugimoto M, Ide T, Goto M, Furuichi Y. Reconsideration of senescence, immortalization and telomere maintenance of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines. Mech Ageing Dev 1999;107:51-60.
25. Bernacki SH, Beck JC, Stankovic AK, Williams EO, Amos J, Snow-Bailey K, Farkas DH, Priez MJ, Hantash FM, Matteson KJ, Monaghan KG, Muralidharan K, Pratt VM, Prior TW, Richie KE, Levin BC, Rohlfs EM, Schaefer FV, Shrimpton AE, Spector EB, Stolle CA, Strom CM, Thibodeau SN, Cole EC, Goodman BK, Stenzel TT. Genetically characterized positive control cell lines derived from residual clinical blood samples. Clin Chem 2005;51:2013-2024.
26. Bowater RP, Wells RD. The intrinsically unstable life of DNA triplet repeats associated with human hereditary disorders. Prog Nucleic Acid Res Mol Biol 2001;66:159-202.
27. Bonilla V, Sobrino F, Eucas M, Pintado E. Epstein-Barr virus transformation of human lymphoblastoid cells from patients with fragile X syndrome induces variable changes on CGG repeats size and promoter methylation. Mol Diagn 2003;7:163-167.
28. Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL, Kistler JP, Albers GW, Pettigrew LC, Adams HP Jr, Jackson CM, Pullicino P; Warfarin-Aspirin Recurrent Stroke Study Group. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001;345:1444-1451.
29. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, Montaner J, Saqqur M, Demchuk AM, Moye EA, Hill MD, Wojner AW; CLOTBUST Investigators. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 2004;351:2170-2178.
30. Camilo O, Goldstein LB. Lower stroke-related mortality in counties with stroke centers: North Carolina Stroke Facilities Survey. Neurology 2005;64:762-763.
31. Kidwell CS, Shephard T, Tonn S, Lawyer B, Murdock M, Koroshetz W, Alberts M, Hademenos GJ, Saver JL. Establishment of primary stroke centers: a survey of physician attitudes and hospital resources. Neurology 2003;60:1452-1456.
32. Herring P, Montgomery S, Yancey AK, Williams D, Fraser G. Understanding the challenges in recruiting blacks to a longitudinal cohort study: the Adventist health study. Ethn Dis 2004;14:423-430.